Evidence map›Paper›PMID 39109224›Full record

ArticleFrontiers in medicine2024

Case report: POEMS syndrome with portal hypertension.

Xiaotong Xu, Changyou Jing, Tong Zhu, Minjie Jiang, Yunlai Fu, Fang Xie, Jianjun Li, Qinghua Meng

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaotong XuBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Changyou JingInterventional Therapy Center for Oncology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Tong ZhuInterventional Therapy Center for Oncology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Minjie JiangBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Yunlai FuBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Fang XieBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Jianjun LiInterventional Therapy Center for Oncology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Qinghua MengDepartment of Oncology, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This patient was an elderly patient with abdominal distension and shortness of breath. According to relevant examinations, his condition was initially considered to be related to cirrhosis, but pathological biopsy confirmed the diagnosis of noncirrhotic portal hypertension of unknown etiology. The portal vein pressure was significantly reduced after transjugular intrahepatic portosystemic shunt (TIPS). Nevertheless, the relief of the hydrothorax and ascites was not significant, and the numbness in both lower limbs gradually worsened. POEMS syndrome was ultimately diagnosed following a comprehensive examination. After two courses of bortezomib combined with dexamethasone, the patient died due to a systemic infection. The clinical symptoms of the patient were atypical, as was the presence of portal hypertension, which hindered the diagnosis of POEMS. Due to the patient's advanced age, the diagnosis was delayed, and the prognosis was poor. This case reminds clinicians that POEMS patients can also have portal hypertension as the main manifestation.

Indexed as

ascitescase reporthydrothoraxPOEMS syndromeportal hypertension

Identifiers

PMID39109224
PMCPMC11300253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.